HILLHOUSE INVESTMENT MANAGEMENT LTD. 13D and 13G filings for TScan Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:11 pm Sale | 2022-12-31 | 13G | TScan Therapeutics, Inc. TCRX | HILLHOUSE INVESTMENT MANAGEMENT LTD. | 0 0.000% | -1,282,976 (Position Closed) | Filing |
| 2022-02-14 4:03 pm Purchase | 2021-12-31 | 13G | TScan Therapeutics, Inc. TCRX | HILLHOUSE INVESTMENT MANAGEMENT LTD. | 1,282,976 6.900% | 1,282,976 (New Position) | Filing |